Gabapentin Dementia Lawsuit in District of Columbia

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Written By
People's Justice Legal Research Team

Statute of Limitations

District of Columbia: 3 years for personal injury (D.C. Code § 12-301(8)). Discovery rule applies — limitations begin when the plaintiff knew or should have known of the injury and its connection to the product.

3 years from discovery of injury

Filing Venue

Where to File in District of Columbia

DC gabapentin cases are filed in the U.S. District Court for the District of Columbia or in DC Superior Court. The federal court has extensive experience with pharmaceutical and regulatory litigation. DC follows contributory negligence with the last clear chance doctrine, which can bar plaintiff recovery if the plaintiff was negligent — though this is rarely an issue in pharmaceutical product liability cases. DC's Consumer Protection Procedures Act provides additional theories including deceptive trade practices related to gabapentin marketing.

District of Columbia Data

Exposure in District of Columbia

Source: IQVIA / DC Board of Pharmacy data

Source: FDA organizational data

Source: DoD / VA healthcare data

FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Back to Gabapentin Dementia Lawsuit Lawsuit Overview